Pfizer's Albert Bourla told investors that major drugmakers are "ready to roll up their sleeves" and build out more direct-to ...

Evan David Seigerman, BMO Capital Markets managing director & healthcare head, joins CNBC's 'Squawk on the Street' to discuss ...

Yahoo Finance's John Hyland tracks Tuesday's top moving stocks and biggest market stories in this Market Minute. Palantir ...

Trump’s drug and chip tariffs could reshape supply chains before they launch. Here’s how escalating rates and hidden costs ...

Meanwhile, Trump continued to amp up pressure on trade Monday, threatening to hike tariffs on India. Separately, in a Tuesday ...

Archer Daniels Midland logged lower profit and revenue in the second quarter, hurt by what Chief Executive Juan Luciano called a challenging environment. Yum Brands logged higher profit and sales in ...

Global markets gave up early gains on Tuesday following the publication of unexpectedly poor US economic data. Euronext ...

US stocks open higher as investors bet on a rate cut and digest earnings. Trump threatens more tariffs and talks Fed chair candidates in interview.

Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter ...

Tariff risks remain high for July CPI. A higher CPI print increases the likelihood of a Fed rate cut. Check out the expected ...

Pfizer stock rose after the drugmaker posted adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, ...

As part of a "strategic alignment" of its pipeline, BioNTech is laying off 90 workers in R&D and corporate roles across two sites in Maryland and Massachusetts, a spokesperson told Fierce. | As part ...